v3.25.2
SHARE-BASED COMPENSATION
6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
SHARE-BASED COMPENSATION

NOTE 12 - SHARE-BASED COMPENSATION

In June 2021, the Company’s shareholders approved the ACRES Commercial Realty Corp. Third Amended and Restated Omnibus Equity Compensation Plan (the "Omnibus Plan") and the ACRES Commercial Realty Corp. Manager Incentive Plan (the "Manager Plan" and together with the Omnibus Plan, the "Plans"). The Omnibus Plan was amended to (i) increase the number of shares authorized for issuance by an additional 1,100,000 shares of common stock, less any shares of common stock issued or subject to awards granted under the Manager Plan; and (ii) extend the expiration date of the Omnibus Plan from June 2029 to June 2031. The maximum number of shares that may be subject to awards granted under the Plans, determined on a combined basis, will be 1,700,817 shares of common stock.

The Omnibus Plan and the Manager Plan are administered by the compensation committee of the Company's Board (the "Compensation Committee"). In 2020, the Compensation Committee and the Board created parameters for equity awards, whereby they are no longer discretionary but are now based upon the Company’s achievement of performance parameters using book value of the common stock as the appropriate benchmark. See Note 16 for a description of awards made under the Manager Plan.

The Company recognized stock-based compensation expense of $585,000 and $1.4 million, respectively, during the three and six months ended June 30, 2025 and $814,000 and $1.3 million, respectively, during the three and six months ended June 30, 2024 related to restricted stock.

In May 2024, the Company issued 295,237 shares of common stock to the Manager and 38,096 shares of common stock to the Company’s directors (with the exception of Messrs. Fentress and Fogel) under the Plans after the Company reached the established per share book value target of $27.00 per share. Each grant vests 25% per year over four years. No shares of common stock were issued to the Manager or the Company’s directors during the three and six months ended June 30, 2025.

Under the Company’s Fourth Amended and Restated Management Agreement, as amended ("Management Agreement"), incentive compensation is paid quarterly. Up to 75% of the incentive compensation may be paid in cash and at least 25% must be paid in the form of an award of common stock, recorded in management fees on the consolidated statements of operations. During the three and six months ended June 30, 2025 and 2024, the Company incurred no incentive compensation payable to the Manager. At June 30, 2025, there was no amount included in Management fee payable - related party on the consolidated balance sheets.

The Company did not issue shares of common stock to the Manager during the six months ended June 30, 2025. During the six months ended June 30, 2024, the Company issued 1,911 shares of common stock to the Manager pertaining to the portion of the fourth quarter 2023 incentive compensation that was payable in shares. Shares of common stock issued under the Management Agreement for incentive compensation vest immediately upon issuance.

The following table summarizes the Company’s restricted common stock transactions:

 

 

 

Manager

 

 

Directors

 

 

Total Number of Shares

 

 

Weighted-Average Grant-Date Fair Value

 

Unvested shares at January 1, 2025

 

 

520,240

 

 

 

54,298

 

 

 

574,538

 

 

$

13.83

 

Issued

 

 

 

 

 

 

 

 

 

 

 

 

Vested

 

 

(223,810

)

 

 

(22,142

)

 

 

(245,952

)

 

 

14.39

 

Unvested shares at June 30, 2025

 

 

296,430

 

 

 

32,156

 

 

 

328,586

 

 

$

13.40

 

 

The unvested shares of restricted common stock that are expected to vest during the following years:

 

 

 

Shares

 

2025

 

 

 

2026

 

 

164,293

 

2027

 

 

82,139

 

2028

 

 

82,154

 

Total

 

 

328,586

 

At June 30, 2025, total unrecognized compensation costs relating to unvested restricted stock was $2.2 million based on the grant date fair value of shares granted. The cost is expected to be recognized over a weighted average period of 2.7 years.